Changes of plasma BNP concentration, LVEDV, LVEF, and NYHA functional class of patients in the valsartan and enalapril groups
| Valsartan | Enalapril | |||
|---|---|---|---|---|
| Baseline | 6 months | Baseline | 6 months | |
| Values are mean (SD). | ||||
| *p<0.05 v baseline; **p<0.001 v baseline; ***p<0.001 v baseline; †p<0.01 v enalapril at 6 months. | ||||
| Plasma BNP (pg/ml) | 237 (180) | 143 (93)* | 235 (154) | 200 (95) |
| LVEDV (ml) | 172 (42) | 151 (45)* | 173 (29) | 172 (33) |
| LVEF (%) | 31 (7) | 39 (10)** | 32 (8) | 35 (10) |
| NYHA class | ||||
| I/II/III | 0/6/19 | 8/15/2*** † | 0/6/19 | 2/14/9* |